53.75
price down icon1.52%   -0.83
after-market Handel nachbörslich: 54.31 0.56 +1.04%
loading

Finanzdaten der Structure Therapeutics Inc Adr-Aktie (GPCR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
132.51%
-23.99
73.79 70.45 56.31 47.06
Operating Income/Loss
132.51%
23.99
-73.79 -70.45 -56.31 -47.06
Income/Loss From Continuing Operations Before Tax
150.57%
33.17
-65.60 -61.52 -46.73 -36.34
Income Tax Expense/Benefit
57.41%
0.17
0.108 0.139 0.098 0.136
Income/Loss From Continuing Operations After Tax
150.23%
33.00
-65.71 -61.66 -46.83 -36.48
Net Income/Loss
150.23%
33.00
-65.71 -61.66 -46.83 -36.48
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.61%
4.194
175.47 172.65 172.05 4.662
Diluted Average Shares
97.61%
4.194
175.47 0.30 172.05 4.662
Basic Earnings Per Share
154.05%
0.20
-0.37 -0.36 -0.27 -0.22
Diluted Earnings Per Share
154.05%
0.20
-0.37 -0.36 -0.27 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):